These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1080668)

  • 1. Studies on the effector cell of anti-tumour immunity in a chemically induced mouse tumour system.
    Whitney RB; Levy JG; Smith AG
    Br J Cancer; 1975 Feb; 31(2):157-63. PubMed ID: 1080668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identity of a T-lymphocyte inhibitor with mouse immunoglobulin in the serum of tumour-bearing mice.
    Levy JG; McMaster R; Kelly B; Whitney RB; Kilburn DG
    Immunology; 1977 Apr; 32(4):475-81. PubMed ID: 305409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of tumor size and surgical resection on cell-mediated immunity in mice.
    Whitney RB; Levy JG; Smith AG
    J Natl Cancer Inst; 1974 Jul; 53(1):111-6. PubMed ID: 4835101
    [No Abstract]   [Full Text] [Related]  

  • 4. Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells.
    Kearney R; Basten A; Nelson DS
    Int J Cancer; 1975 Mar; 15(3):438-50. PubMed ID: 1079792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sera from tumor-bearing mice on mitogen and allogeneic cell stimulation of normal lymphoid cells.
    Whitney RB; Levy JG
    J Natl Cancer Inst; 1975 Mar; 54(3):733-41. PubMed ID: 123599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a T-lymphocyte inhibitor in the serum of tumour-bearing mice.
    Levy JG; Smith AG; Whitney RB; McMaster R; Kilburn DG
    Immunology; 1976 Apr; 30(4):565-73. PubMed ID: 131782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of a cytotoxic factor by murine spleen cells in the presence of a tumour allograft.
    Vaillier D; Donner M; Burg C
    Experientia; 1972 Nov; 28(11):1352-3. PubMed ID: 4638919
    [No Abstract]   [Full Text] [Related]  

  • 8. The stimulatory effect of tumor bearing upon the T- and B-cell subpopulations of the mouse spleen.
    Konda S; Nakao Y; Smith RT
    Cancer Res; 1973 Oct; 33(10):2247-56. PubMed ID: 4147496
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV; Pettey CL; Collins JJ
    Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of exogenous interleukin 2 on the functional activity of immunocompetent cells in mice with transplanted tumors].
    Semenova-Kobzar' RA; Kushko LIa; Iudin VM; Koval'chuk EV; Berezhnaia NM
    Eksp Onkol; 1986; 8(2):39-42. PubMed ID: 2938929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of immune competence after tumour resection in mice: correlation with loss of suppressor elements.
    Gasocyne RD; Whitney RB; Levy JG
    Br J Cancer; 1978 Feb; 37(2):190-8. PubMed ID: 305254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. V. Transfer of protective immunity with H-2 identical immune T cells from B10.D2 mice.
    Schirrmacher V
    Int J Cancer; 1979 Jul; 24(1):80-6. PubMed ID: 314423
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanism of loss of natural killer activity in P815 ascites tumor bearing DBA/2 mice.
    Saxena RK; Saxena QB; Adler WH
    Nat Immun Cell Growth Regul; 1983-1984; 3(1):34-42. PubMed ID: 6235448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Method of assessing the functional activity of tumor-associated suppressor cells].
    Iudin VM; Semenova-Kobzar' RA; Kushko LIa
    Eksp Onkol; 1984; 6(6):37-41. PubMed ID: 6241144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for splenic suppressor cells in C3H/He, T-cell-deprived C3H/He, and nude mice bearing a 3-methylcholanthrene-induced fibrosarcoma.
    Poupon MF; Kolb JP; Lespinats G
    J Natl Cancer Inst; 1976 Dec; 57(6):1241-7. PubMed ID: 1087353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of immune status to the efficacy of immunotherapy in preventing tumour recurrence in mice.
    Levy JG; Whitney RB; Smith AG; Panno L
    Br J Cancer; 1974 Oct; 30(4):289-96. PubMed ID: 4447774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-specific cytotoxicity of spleen cells in mice bearing transplanted chemically induced fibrosarcomas.
    Mantovani A; Evans R; Alexander P
    Br J Cancer; 1977 Jul; 36(1):35-40. PubMed ID: 889683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor cells in mice with murine mammary tumor virus-induced mammary tumors. I. Inhibition of mitogen-induced lymphocyte stimulation.
    Rudczynski AB; Mortensen RF
    J Natl Cancer Inst; 1978 Jan; 60(1):205-11. PubMed ID: 203703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell-dependent suppression of antibody production. I. Characteristics of suppressor T cells following tolerance induction.
    Basten A; Miller JF; Loblay R; Johnson P; Gamble J; Chia E; Pritchard-Briscoe H; Callard R; McKenzie IF
    Eur J Immunol; 1978 May; 8(5):360-70. PubMed ID: 308454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity to a 3-methylcholanthrene-induced fibrosarcoma in the C57BL/6 mouse: in vivo analysis by the adoptive tumor neutralization test.
    Poupon MF; Lespinats G; Kolb JP; Payelle B
    J Natl Cancer Inst; 1979 Apr; 62(4):989-94. PubMed ID: 311871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.